ATE9091T1 - Substituierte phenoxyacetate cyclischer amine, verfahren zu ihrer herstellung, ihre anwendung als heilmittel und sie enthaltende pharmazeutische zusammensetzungen. - Google Patents

Substituierte phenoxyacetate cyclischer amine, verfahren zu ihrer herstellung, ihre anwendung als heilmittel und sie enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE9091T1
ATE9091T1 AT81400670T AT81400670T ATE9091T1 AT E9091 T1 ATE9091 T1 AT E9091T1 AT 81400670 T AT81400670 T AT 81400670T AT 81400670 T AT81400670 T AT 81400670T AT E9091 T1 ATE9091 T1 AT E9091T1
Authority
AT
Austria
Prior art keywords
cyclic amines
phenoxyacetate
medicines
substitute
production
Prior art date
Application number
AT81400670T
Other languages
English (en)
Inventor
Jean-Jacques Godfroid
Jean Thuillier
Original Assignee
Anvar Agence Nationale De Valorisation De La Recherche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anvar Agence Nationale De Valorisation De La Recherche filed Critical Anvar Agence Nationale De Valorisation De La Recherche
Application granted granted Critical
Publication of ATE9091T1 publication Critical patent/ATE9091T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT81400670T 1980-04-30 1981-04-28 Substituierte phenoxyacetate cyclischer amine, verfahren zu ihrer herstellung, ihre anwendung als heilmittel und sie enthaltende pharmazeutische zusammensetzungen. ATE9091T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8009885A FR2481702A1 (fr) 1980-04-30 1980-04-30 Phenoxyacetates substitues d'amines cycliques, procede d'obtention, applications a titre de medicaments et compositions pharmaceutiques les contenant
EP81400670A EP0039636B1 (de) 1980-04-30 1981-04-28 Substituierte Phenoxyacetate cyclischer Amine, Verfahren zu ihrer Herstellung, ihre Anwendung als Heilmittel und sie enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE9091T1 true ATE9091T1 (de) 1984-09-15

Family

ID=9241573

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81400670T ATE9091T1 (de) 1980-04-30 1981-04-28 Substituierte phenoxyacetate cyclischer amine, verfahren zu ihrer herstellung, ihre anwendung als heilmittel und sie enthaltende pharmazeutische zusammensetzungen.

Country Status (7)

Country Link
US (1) US4425352A (de)
EP (1) EP0039636B1 (de)
JP (1) JPS56169671A (de)
AT (1) ATE9091T1 (de)
DE (1) DE3165641D1 (de)
ES (1) ES8202797A1 (de)
FR (1) FR2481702A1 (de)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL123438C (de) * 1959-04-15
GB886437A (en) * 1959-07-15 1962-01-10 Beecham Res Lab Improvements in or relating to basic esters of etherified benzilic acids
US3448110A (en) * 1966-10-03 1969-06-03 Sandoz Ag Derivatives of isobutyric acid
GB1209750A (en) * 1967-05-09 1970-10-21 Rech S Et D Applic Scient Et M Improvements in or relating to 2,2,6,6,-tetramethyl piperidine and 1,2,3,6,-tetrahydro-2,2,6,6-tetramethyl pyridine derivatives
US4233298A (en) 1969-01-31 1980-11-11 Orchimed Sa Esters of p-carbonylphenoxy-isobutyric acids
US3708587A (en) * 1970-06-08 1973-01-02 Ciba Geigy Corp Hypocholesterolemic phenoxy-aliphatic acid compositions
US3683086A (en) * 1970-07-13 1972-08-08 Sandoz Ag Derivatives of acetic acid for the alleviation of hyperlipemia
US3755417A (en) * 1971-10-04 1973-08-28 American Home Prod Tris (4-chlorophenoxy)acetic acid and esters thereof
DE2358789A1 (de) * 1973-02-07 1975-06-05 Merck Patent Gmbh Hydratropasaeure-derivate und verfahren zu ihrer herstellung
NL7416412A (nl) * 1973-12-27 1975-07-01 Siegfried Ag Werkwijze ter bereiding van nieuwe cholesterol- gende verbindingen.

Also Published As

Publication number Publication date
ES501743A0 (es) 1982-03-01
US4425352A (en) 1984-01-10
ES8202797A1 (es) 1982-03-01
EP0039636A1 (de) 1981-11-11
DE3165641D1 (en) 1984-09-27
EP0039636B1 (de) 1984-08-22
JPS56169671A (en) 1981-12-26
FR2481702B1 (de) 1983-05-27
FR2481702A1 (fr) 1981-11-06

Similar Documents

Publication Publication Date Title
ATE9793T1 (de) 5-oxo- und 5-thioxoproline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE20887T1 (de) Neue n-phenyl-n'-cycloalkylalkanoyl-piperazine und verfahren zu deren herstellung.
DE68914488T2 (de) 2-(2-Hydroxy-3-phenoxypropylamino)ethylphenoxyacetamide, Verfahren und Zwischenprodukte zu deren Herstellung.
DK0587088T3 (da) Substituerede cyclohexan-derivater, fremgangsmåde til deres fremstilling og anvendelsen af forbindelserne til behandling af sygdomme
DE59010189D1 (de) Aminosäurederivate mit reninhemmenden Eigenschaften, Verfahren zu deren Herstellung, diese enthaltende Mittel und deren Verwendung
ATE66609T1 (de) Loesungen von oxazaphosphorinen mit verbesserter stabilitaet und verfahren zu deren herstellung.
ATE161717T1 (de) Antivirale mittel
ATE193531T1 (de) Phenyl-carboxamide-isoxazole-derivate und salze, verfahren zu ihrer herstellung ihre anwendung als arzneimittel und pharmazeutische zusammensetzungen die sie enthalten
ATE152707T1 (de) Neue naphthalin-amide und sulfonamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE3575554D1 (de) Aminosaeurederivate mit antitumoraktivitaet sowie diese derivate enthaltende zusammensetzungen.
DE58905462D1 (de) Enzym-hemmende Aminosäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung.
ATE107298T1 (de) 3-aminochroman-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3769563D1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
ATE116647T1 (de) Thiophenderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE9091T1 (de) Substituierte phenoxyacetate cyclischer amine, verfahren zu ihrer herstellung, ihre anwendung als heilmittel und sie enthaltende pharmazeutische zusammensetzungen.
NO873564L (no) Nye tyroninderivater.
DE3676378D1 (de) Isoxazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutischen praeparate.
ATE28858T1 (de) Derivate von n-(methoxyphenacyl)aminen, ihre therapeutische verwendung und verfahren zu ihrer herstellung.
DE3886185D1 (de) 2-Thiazolidinon-Derivate und diese enthaltende pharmazeutische Präparate, Verfahren zu deren Herstellung und deren Verwendung.
ATE123776T1 (de) Aminoalkylchromone, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
ATE74909T1 (de) 5-aminopentanitrilderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
SE8205256L (sv) Tricykliska kinazolinoner
ATE12238T1 (de) Neue ketale von 3'''-dehydro-cardenolidtridigitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE15197T1 (de) Neue diglycidyl-pteridin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung in arzneimitteln mit cytostatischer wirkung.
ATE139780T1 (de) Amidderivate von 1-amino-octahydropyrido(2,1- c>(1,4>oxazin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen